RankingsPricing
  1. JP-listed companies
  2. Kidswell Bio Corporation
  3. Financials
  4. Revenue

Kidswell Bio Corporation【JP:4584】

Market cap
¥11.1B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 20255,082+109.03%
Mar 31, 20242,431-12.43%
Mar 31, 20232,776+76.92%
Mar 31, 20221,569+57.47%
Mar 31, 2021997-7.53%
Mar 31, 20201,078+5.48%
Mar 31, 20191,022-3.59%
Mar 31, 20181,060-2.72%
Mar 31, 20171,089-6.16%
Mar 31, 20161,161+260.91%
Mar 31, 2015322+6.74%
Mar 31, 2014301+397.82%
Mar 31, 201361-70.77%
Mar 31, 2012207

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)